GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Levitee Labs Inc (XCNQ:LVT) » Definitions » EPS (Diluted)

Levitee Labs (XCNQ:LVT) EPS (Diluted) : C$-0.18 (TTM As of Jun. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Levitee Labs EPS (Diluted)?

Levitee Labs's Earnings per Share (Diluted) for the three months ended in Jun. 2022 was C$-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was C$-0.18.

Levitee Labs's EPS (Basic) for the three months ended in Jun. 2022 was C$-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2022 was C$-0.18.

Levitee Labs's EPS without NRI for the three months ended in Jun. 2022 was C$-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2022 was C$-0.16.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Levitee Labs EPS (Diluted) Historical Data

The historical data trend for Levitee Labs's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Levitee Labs EPS (Diluted) Chart

Levitee Labs Annual Data
Trend Sep20 Sep21
EPS (Diluted)
-0.01 -0.27

Levitee Labs Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only -0.06 -0.09 -0.03 -0.05 -0.01

Competitive Comparison of Levitee Labs's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Levitee Labs's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Levitee Labs's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Levitee Labs's PE Ratio distribution charts can be found below:

* The bar in red indicates where Levitee Labs's PE Ratio falls into.



Levitee Labs EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Levitee Labs's Diluted EPS for the fiscal year that ended in Sep. 2021 is calculated as

Diluted EPS (A: Sep. 2021 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-11.403-0)/42.130
=-0.27

Levitee Labs's Diluted EPS for the quarter that ended in Jun. 2022 is calculated as

Diluted EPS (Q: Jun. 2022 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.497-0)/75.465
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Levitee Labs  (XCNQ:LVT) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Levitee Labs EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Levitee Labs's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Levitee Labs (XCNQ:LVT) Business Description

Traded in Other Exchanges
N/A
Address
800 West Pender Street, Suite 215, Vancouver, CAN, V6C 2V6
Levitee Labs Inc is a functional mushrooms company, focused on the development and sale of high potency mushroom extract nutraceuticals and supplies and equipment for mushroom cultivation. The company believes, based on a growing body of research, that mushrooms can be an effective way to enhance wellbeing and potentially treat various kinds of mental and physical health problems. The medical services segment is engaged in providing medical treatment. The selling products segment is into buying and selling products Substantial revenue is generated from medical services operations.

Levitee Labs (XCNQ:LVT) Headlines

No Headlines